Covance

Covance (NYSE: CVD), with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1 billion, global operations in 18 countries, and more than 7,000 employees worldwide.Worldwide, Covance helps pharmaceutical and biotech companies of all sizes fulfill their research and development, clinical trial, regulatory and marketing-support needs.

Contact Details: 210 Carnegie Center Princeton New Jersey 08540 United States of America Tel: 1 888-Covance (268-2623 Fax: Email: WWW: www.covance.com/

Loading...

Recent Publications by Covance:
Measurement of vitamin D in foods and nutritional supplements by liquid chromatography/tandem mass spectrometry. Vitamin D is a fat-soluble vitamin with great nutritional interest. An...	18th November, 2009	Covance Laboratories Inc., 3301 Kinsman Blvd, Madison, WI 53704, USA.	J AOAC Int. 2009 Sep-Oct;92(5):1327-35.
Standing on the shoulders of giants: Dean Franklin and his remarkable contributions to physiological measurements in animals. The use of electronic instrumentation to monitor physiological function in...	17th November, 2009	Covance Laboratories Incorporated, Madison, Wisconsin 53704-2523, USA.	Adv Physiol Educ. 2009 Sep;33(3):144-56. DOI Direct Link
Valuation of transfusion-free living in MDS: results of health utility interviews with patients. BACKGROUND: This study measured how myelodysplastic syndrome (MDS)...	5th November, 2009		Health Qual Life Outcomes. 2009 Sep 8;7:81. DOI Direct Link
Adverse reactions to over-the-counter cough and cold products among children: the cases managed out of hospitals. BACKGROUND AND OBJECTIVE: Prompted by continuing concerns about the safety...	23rd October, 2009	Covance Periapproval Services, Princeton, NJ 08540, USA.	J Clin Pharm Ther. 2009 Jun;34(3):313-8. DOI Direct Link
Two-injection workflow for a liquid chromatography/LTQ-Orbitrap system to complete in vivo biotransformation characterization: demonstration with buspirone metabolite identification. The relatively high background matrix in in vivo samples typically poses...	21st October, 2009	Covance Laboratories Inc., 3301 Kinsman Boulevard, Madison, WI 53704-2523,	Rapid Commun Mass Spectrom. 2009 Sep;23(18):3003-12. DOI Direct Link
→View more Covance research publications.

Press Releases on Covance:
Rules-Based Medicine Forms Biomarker Alliance With Covance Inc.	18th November, 2009	Rules-Based Medicine, Inc.	SAN DIEGO, Nov. 18 /PRNewswire/ -- Rules-Based Medicine, Inc. (RBM) today announced it has entered into a biomarker alliance and services agreement with Covance Inc. (NYSE: CVD) that will provide
Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc.	18th November, 2009	Covance Inc.	PRINCETON, N.J., Nov. 18 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD), a leading provider of drug development services, announced today that it entered into a biomarker alliance and services
Mersana Therapeutics Provides Clinical Update from Ongoing Phase 1 Study of XMT-1001 in Patients with Advanced Solid Tumors	17th November, 2009	Mersana Therapeutics, Inc.	CAMBRIDGE, Mass., Nov. 17 /PRNewswire/ -- Mersana Therapeutics, a platform-based cancer therapeutics company, announced today additional preliminary results from an ongoing Phase 1 study of its lead
Covance To Present at Credit Suisse Healthcare Conference	10th November, 2009	Covance Inc.	PRINCETON, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today announced that it will present at the Credit Suisse Healthcare Conference on Thursday, November 12, 2009 at 1:00 p.m.
NeurogesX Expands Commercial Operations Leadership Team	5th November, 2009	NeurogesX	-- Timothy Arendt has been named Vice President Sales. He will implement and manage the U.S. specialty sales force for Qutenza(TM). -- Amy C. Cavers has joined NeurogesX as

BioNews Results for Covance:
Dr. John Mills and Joseph Gentile Join Board of Directors of ChanTest Corporation	Montana's News Station:  Nov 12 2009 1:15PM Matching: covance
Dr. John Mills and Joseph Gentile Join Board of Directors of ChanTest Corporation	KOTA Territory News:  Nov 12 2009 11:34AM Matching: covance
Dr. John Mills and Joseph Gentile Join Board of Directors of ChanTest Corporation	KSLA:  Nov 12 2009 6:04AM Matching: covance
Dr. John Mills and Joseph Gentile Join Board of Directors of ChanTest Corporation	Genetic Engineering News:  Nov 12 2009 4:20AM Matching: covance
Covance To Present at Credit Suisse Healthcare Conference	Pharma Live:  Nov 11 2009 6:38AM Matching: covance
Promote your company here: BioNewsCast - Press Release Distribution	→View more Covance news.

Covance Clinical Trials:
Effect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated Suspension

Covance Patents:
US Patent No.	Title
7476726	Method of producing and purifying endostatin protein
6934578	Method and apparatus for interactive annotation and measurement of time series data with automatic marker sequencing
6233395	Method for quantitative iris colorimetry

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 57 individuals from Covance using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 379 times since April 2007, the link to the organisation's website has been followed 83 times

Recent Search Terms used to find this page: covance and kim1 | .

Search for more companies in Princeton

Search for more companies in New Jersey

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Covance